EX-23.1 4 ex231201610-k.htm EXHIBIT 23.1 Exhibit

Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We hereby consent to the incorporation by reference in the Registration Statements on Forms S‑3 (File Nos. 333‑202009 and 333-202252) and Forms S‑8 (File Nos. 333‑82292, 333‑131656, 333‑148682, 333‑159938, 333‑168786, 333-182821, 333‑190435, 333‑197873, 333-203924 and 333-211277) of AMAG Pharmaceuticals, Inc. of our report dated February 17, 2017 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.

/s/ PricewaterhouseCoopers LLP
 
Boston, Massachusetts
 
February 17, 2017